Literature DB >> 2904495

Medullary regions mediating atonia.

Y Y Lai1, J M Siegel.   

Abstract

Electrical stimulation studies have implicated the medial medulla in the inhibition of muscle tone. In the present report we present evidence for suppression of muscle tone by chemical activation of the medial medulla. We find 2 distinct zones within the classically defined medial medullary inhibitory area. A rostral region corresponding to the nucleus magnocellularis (NMC) is sensitive to glutamate. Atonia produced by activation of this region is mediated by non-NMDA receptors. A caudal region, corresponding to the nucleus paramedianus (NPM) is sensitive to ACh. Atonia produced by activation of this region is mediated by muscarinic receptors. Activation of these regions both in acute decerebrate and intact cats suppresses muscle tone. We find that the cholinoceptive dorsolateral pontine region, previously implicated in atonia control, can be activated by glutamate-sensitive non-NMDA receptors. Microinjection of atropine into the NPM or of glutamylglycine into the NMC blocks atonia elicited by pontine carbachol injection. The medullary regions identified here are hypothesized to mediate the suppression of muscle tone that occurs in rapid eye movement sleep and in cataplexy and may have a role in postural control in waking.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2904495      PMCID: PMC6569564     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  61 in total

1.  Activation of pontine and medullary motor inhibitory regions reduces discharge in neurons located in the locus coeruleus and the anatomical equivalent of the midbrain locomotor region.

Authors:  B Y Mileykovskiy; L I Kiyashchenko; T Kodama; Y Y Lai; J M Siegel
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

2.  Cessation of activity in red nucleus neurons during stimulation of the medial medulla in decerebrate rats.

Authors:  Boris Y Mileykovskiy; Lyudmila I Kiyashchenko; Jerome M Siegel
Journal:  J Physiol       Date:  2002-12-15       Impact factor: 5.182

3.  Neuropharmacology of Sleep and Wakefulness.

Authors:  Christopher J Watson; Helen A Baghdoyan; Ralph Lydic
Journal:  Sleep Med Clin       Date:  2010-12

Review 4.  Nitric oxide (NO) and obstructive sleep apnea (OSA).

Authors:  James S J Haight; Per Gisle Djupesland
Journal:  Sleep Breath       Date:  2003-06       Impact factor: 2.816

Review 5.  The pontine REM switch: past and present.

Authors:  Patrick M Fuller; Clifford B Saper; Jun Lu
Journal:  J Physiol       Date:  2007-09-20       Impact factor: 5.182

Review 6.  Rapid eye movement sleep behavior disorder and the link to alpha-synucleinopathies.

Authors:  Daniel A Barone; Claire Henchcliffe
Journal:  Clin Neurophysiol       Date:  2018-05-29       Impact factor: 3.708

Review 7.  The developmental decrease in REM sleep: the role of transmitters and electrical coupling.

Authors:  Edgar Garcia-Rill; Amanda Charlesworth; David Heister; Meijun Ye; Abdallah Hayar
Journal:  Sleep       Date:  2008-05       Impact factor: 5.849

8.  Alterations of the brain network in idiopathic rapid eye movement sleep behavior disorder: structural connectivity analysis.

Authors:  Kang Min Park; Ho-Joon Lee; Byung In Lee; Sung Eun Kim
Journal:  Sleep Breath       Date:  2018-10-12       Impact factor: 2.816

Review 9.  Pontine reticular formation (PnO) administration of hypocretin-1 increases PnO GABA levels and wakefulness.

Authors:  Christopher J Watson; Haideliza Soto-Calderon; Ralph Lydic; Helen A Baghdoyan
Journal:  Sleep       Date:  2008-04       Impact factor: 5.849

10.  Medullary circuitry regulating rapid eye movement sleep and motor atonia.

Authors:  Ramalingam Vetrivelan; Patrick M Fuller; Qingchun Tong; Jun Lu
Journal:  J Neurosci       Date:  2009-07-22       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.